DE69207181D1 - Verfahren zur inaktivierung von viren - Google Patents

Verfahren zur inaktivierung von viren

Info

Publication number
DE69207181D1
DE69207181D1 DE69207181T DE69207181T DE69207181D1 DE 69207181 D1 DE69207181 D1 DE 69207181D1 DE 69207181 T DE69207181 T DE 69207181T DE 69207181 T DE69207181 T DE 69207181T DE 69207181 D1 DE69207181 D1 DE 69207181D1
Authority
DE
Germany
Prior art keywords
liposaccharide
solution
inactivating viruses
protein
aldohexose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69207181T
Other languages
English (en)
Inventor
Roland Schmitthaeusler
Wisdom Klagba
Goffic Francois Le
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VEGATEC
Original Assignee
VEGATEC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VEGATEC filed Critical VEGATEC
Application granted granted Critical
Publication of DE69207181D1 publication Critical patent/DE69207181D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16661—Methods of inactivation or attenuation
    • C12N2710/16663—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69207181T 1991-03-29 1992-03-27 Verfahren zur inaktivierung von viren Expired - Lifetime DE69207181D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR919103892A FR2674536B1 (fr) 1991-03-29 1991-03-29 Procede d'inactivation de virus et composition pharmaceutique pour l'inactivation de virus.
PCT/FR1992/000276 WO1992017570A1 (fr) 1991-03-29 1992-03-27 Procede d'inactivation de virus et composition pharmaceutique pour l'inactivation de virus

Publications (1)

Publication Number Publication Date
DE69207181D1 true DE69207181D1 (de) 1996-02-08

Family

ID=9411308

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69207181T Expired - Lifetime DE69207181D1 (de) 1991-03-29 1992-03-27 Verfahren zur inaktivierung von viren

Country Status (7)

Country Link
EP (1) EP0578726B1 (de)
JP (1) JPH06511383A (de)
AT (1) ATE132186T1 (de)
CA (1) CA2107092A1 (de)
DE (1) DE69207181D1 (de)
FR (1) FR2674536B1 (de)
WO (1) WO1992017570A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19528221C2 (de) * 1995-08-01 1998-10-22 Blutspendedienst Der Drk Lande Verfahren zur Herstellung eines virussicheren, therapeutischen Präparates aus Humanplasma

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2475572A1 (fr) * 1980-02-11 1981-08-14 Pasteur Institut Procede pour l'obtention de fragments de virus a enveloppe lipidique, en particulier d'antigenes utilisables comme vaccins, produits obtenus et applications
AT385203B (de) * 1985-04-26 1988-03-10 Immuno Ag Verfahren zur herstellung einer fruehsommermeningoenzephalitis-virus (fsme-virus)-vakzine

Also Published As

Publication number Publication date
CA2107092A1 (fr) 1992-09-30
JPH06511383A (ja) 1994-12-22
WO1992017570A1 (fr) 1992-10-15
ATE132186T1 (de) 1996-01-15
FR2674536A1 (fr) 1992-10-02
EP0578726B1 (de) 1995-12-27
FR2674536B1 (fr) 1994-10-21
EP0578726A1 (de) 1994-01-19

Similar Documents

Publication Publication Date Title
ATE113272T1 (de) Verfahren zur stabilisierung einer festen pharmazeutischen zubereitungsform von cyclischen aminosäuren.
DE68914488T2 (de) 2-(2-Hydroxy-3-phenoxypropylamino)ethylphenoxyacetamide, Verfahren und Zwischenprodukte zu deren Herstellung.
DE69021455D1 (de) Verfahren zur Herstellung von Ascorbinsäure.
ATE161013T1 (de) Verfahren zum reinigen von 20 cs)-camptothecin
ATE164065T1 (de) Neues verfahren zur behandlung von depression
EP0192988A3 (en) Process for solubilization, purification and characterization of protein from insoluble protein aggregates or complexes and compositions of matter therefrom
NO952205L (no) Heterocykliske karbamater, fremgangsmåte for fremstilling derav og medikamenter
ES2081817T3 (es) Polipeptido con secuencias principales repetidas que se fijan en la celula.
ATE70067T1 (de) Peptidaminoalkoholderivate, welche ein tetrasubstituiertes kohlenstoffatom besitzen, hemmungsstoffe von renin und proteasesaeuren, verfahren zur herstellung und pharmazeutische zusammensetzungen.
PT87537A (pt) Process for the preparation of cyclic anticoagulant peptides
PT87536A (pt) Process for the preparation of cyclic anticoagulant peptides
DK482185A (da) Peptider, deres fremstilling og anvendelse som laegemidler
PT87535A (pt) Process for the preparation of novel anf peptide derivatives and of pharmaceutical compositions containing the same
DE69104220T2 (de) Verfahren zur Herstellung von direktkomprimierten, Cephalosporansäure Derivate enthaltendenTabletten.
DE3885818D1 (de) Trinatriumsalz des 2,4,6-Trimercapto-s-triazin-nonahydrats und Verfahren zur Herstellung.
DE69207181D1 (de) Verfahren zur inaktivierung von viren
ATE96805T1 (de) Verfahren zur rueckgewinnung rekombinanter proteine.
DE68912809T2 (de) Verfahren zur Herstellung von Bis(2,2,6,6-tetramethyl-4-piperidyl)amin.
DK0403458T3 (da) Hidtil ukendte polypeptider og anvendelse deraf
ATE114468T1 (de) Ethyl-(+)-apovincaminat zur behandlung der demyelinisierung klinischer erscheinungen autoimmunen ursprungs.
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
DK0422215T3 (da) Antibakterielle peptider og antimalariapeptider
FR2555576B1 (fr) Derives de n-(methoxyphenacyl)-amine, utilisation notamment en therapeutique et procede de preparation
DK102787D0 (da) Isohexidnucleosider og farmaceutiske praeparater indeholdende disse

Legal Events

Date Code Title Description
8332 No legal effect for de